-
Font Size:
After 18 months in development, Google (GOOG) has unveiled its online personal health record [PHR] storage system, Google Health.
Google brings its considerable know how and infrastructure to the space. The successful trial at the Cleveland Clinic validated the secure exchange of patient data between the Clinic and a secure Google profile.
The
excitement was palpable. According to C. Martin Harris, the Cleveland
Clinic’s chief information officer, the trial, limited to 1,600
patients, was quickly overbooked.
Privacy Concerns Over-Hyped
Google’s approach bypasses the key problem in being able to integrate health data from multiple sources. Current regulations, designed to protect people’s privacy, make sharing medical data difficult. But Google places control in the hands of the user. If the user inputs data and then shares access with to this data with others, privacy issues are largely averted.
Your Google Health profile includes standard PHR data like notices, drug interactions, conditions, medications, allergies, procedures, immunization and test results. Google places your data in the clouds; it’s accessible with the same password you may use for email and other Google services – if this password is compromised your records are at risk.
I spoke with Dr. Leonard Finn this weekend, who reports his existing PHR system is both cumbersome and inefficient. The savings he envisioned when switching over to an electronic health record system were never realized. Currently Finn stores his data on a server in his office, a decision he believes will curtail the risk of privacy violations.
Finn looks forward to learning more about Google Health; if anyone can make data safe it’s Google. A public relations nightmare would ensnare the company if even a modest breach of privacy were to occur.
Robust System Architecture
Google Health offers a number of tools including a ‘health topics’ section which allows users to find information (symptoms, causes, treatment, news, etc.) in a robust library of disease states. This would seem to run on a collision course with WebMD (WBMD). Users can search for physicians in a number of ways.
The secret sauce is the ability to add or import your patient records and prescription data. Google has established data portability relationships with:
- Beth Israel Deaconess Medical Center: Patient site connects patients to medical records online.
- Cleveland Clinic MyChart: Online health management tool that gives Cleveland Clinic patients access to their medical records.
- Longs Drug Stores: Import prescription history from Longs.com.
- Walgreens Pharmacy: Import prescription history from Walgreens.com.
- Medco: Online pharmacy management and mail order drugs.
- RxAmerica: Discounts on prescriptions at retail pharmacies and delivery through a mail order prescription program.
- MinuteClinic: Retail-based health care and a subsidiary of CVS (CVS) Caremark; medical care for common illnesses.
- Quest Diagnostics (DGX): Laboratory testing, information, and services; access lab test results online.
Monetization Opportunities Abound
Monetization opportunities abound. While the site remains ad-free, Google is in a unique position to offer the services gratis until it gains significant market share.
Down the road, I believe Google will support the service through advertising. Think GMAIL for medicine – with ads for doctors, pharmacies, drugs, and devices peppered beside your personal health records and delivered using the same contextual advertising Google is known for.
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
ETFs In Focus
-
Editor's Picks
-
Most Popular
- Railway Stocks Haul Transportation ETF to Solid Returns
- Protect Your Portfolio: Here Comes the Squeeze
- The Most Important Price in an Economy
- Income Planning and Safe Withdrawal Rates
- Solvency and Liquidity: Non-Identical Twins
- The Great Inflation Debate
- Full list of Editor's Picks »
- The Disconnect Between Supply and Demand in Gold & Silver Markets »
- The Great Consumer Crash of 2009 »
- Cramer Continues to Dig a Sirius Hole for Himself »
- Petrobras: Buy and Sit Tight Like Soros »
- Apple: Great Company with Lofty Valuation - Due for Pullback »
- Interview with Jim Rogers, Part I: Bigger Financial Shocks Loom »
- Jim Cramer's Unnecessary Beating Over Sirius »
- Wall Street Breakfast: Must-Know News »
- 5 Impressive Stocks in This Difficult Market »
- Wall Street Breakfast: Must-Know News »
- Forget $100 a Barrel - Oil Will Plummet to $30 »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Why I'm Buying Amylin Now
- HP: Good To Grow
- Screener Picks: Three Mega-cap Long Picks
- Financial Downgrades Down Markets - Fast Money Recap (8/19/08)
- Transocean: Drilling Deep for Profits
- Whose Freddie Investment Thesis Is Right?
- Steel Dynamics: Bullish with a Share Repurchase Program
- E-Trade Financial Carries High Risk-Reward
- Interested in Bank of America? Consider the Preferred Shares
- Northgate: Mid-Tier Gold Producer with Strong Cashflow
- Full list of Long Ideas »
- Salesforce.com: It's All About the Guidance
- Three Casino Stocks Rolling Over
- New Web Site For Short Sellers: You Gotta Love Capitalism
- Commodity Carnage: Where to Turn Next?
- Fannie and Freddie Shareholders Run for the Exit
- Goldman: Readying Short Position Initiation Sequence
- Apple: Great Company with Lofty Valuation - Due for Pullback
- Russia's Too Risky - Barron's
- Fannie, Freddie Shareholders Will Be Left Holding the Bag - Barron's
- Pilgrim's Pride: The Weakest Link in the Food Chain
- Full list of Short Ideas »
- Real Buys - Cramer's Mad Midday (8/20/08)
- Coke vs. Pepsi - Cramer's Mad Money (8/19/08)
- Clean Energy - Cramer's Lightning Round (8/19/08)
- Still Growing - Cramer's Mad Midday (8/19/08)
- Which Stock to Pick - Cramer's Mad Money (8/18/08)
- Buy Weyerhauser - Cramer's Lightning Round (8/18/08)
- The Price of Oil - Cramer's Mad Money (8/18/08)
- Great Execution Pick - Cramer's Mad Money (8/14/08)
- Beaten Down Buy - Cramer's Lightning Round (8/14/08)
- The Fry Guy - Cramer's Midday Mad Money (8/14/08)
- Full list of Cramers Picks »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »



This article has 8 comments:
Google should just stick with search. After all, they already eat WebMD's lunch by taking the majority of Pharma ad dollars already.
techwatch.reviewk.com/.../
Agreed, Google should “just stick to search” and ignore the billion dollar electronic medical record storage market…
Especially since they’re going to get “zero traction” (a bold statement for a supposed market research firm).
With Google's market penetration in other verticals, and their ability to store all your information (Gmail, Google Docs, Google Reader) I wouldn’t discount them just yet.
Even modest rates of adoption could create what many would consider a home run – were it not for the high standards investors have set. Nothing will compare to search as far as generating revenues is concerned.
And the data may be licensed from ADAM, but Google has the ability to integrate it into their search results. The competitive playing field is hardly level.
B) Google already has ADAM and every other content provider integrated into their search results.
C) Google already is the leader in the online health ad space.
D) Nothing about Google Health inidicates that they can gain traction with users or make money. Just saying that a market is "a billion dollar industry" doesnt make it so. In fact, I dont know anyone who is making any money in PHR field.
My point here is simple: broad, general statements that have no historical fact or logical assumptions are useless. And how investors usually get burned....
b) integrated, as in prioritized, a la Google Maps in local search: www.google.com/search?...
c) agreed
d) sounds like a pretty broad, general statement.
But I dont think Google Health represents any additional value to cause any investor to buy Google stock. And this is a website about investing, right?